NEMAURA MEDICAL INC vs. NVIDIA Corporation
NVIDIA Corporation (NVDA) comes out ahead, leading on 3 of 3 compared factors.
Size & Scale
| NMRD | NVDA | |
|---|---|---|
| Market Cap | — | $5.65 trillion |
| Revenue (TTM) | — | $302.97 billion |
| Net Income (TTM) | $-10,650,933 | $192.88 billion |
NVDA leads on 2 of 2 size & scale factors.
Valuation
| NMRD | NVDA | |
|---|---|---|
| P/E Ratio | — | 29.58 |
| Price / Book | — | 24.67 |
| Price / Sales | — | 18.65 |
NMRD and NVDA split the valuation factors evenly.
Profitability
| NMRD | NVDA | |
|---|---|---|
| Net Margin | — | 63.66% |
| Return on Equity | 59.75% | 84.23% |
NVDA leads on 1 of 1 profitability factors.
Dividend
| NMRD | NVDA | |
|---|---|---|
| Dividend Yield | — | 0.43% |
| Payout Ratio | — | 12.64 |
NMRD and NVDA split the dividend factors evenly.
Risk & Sentiment
| NMRD | NVDA | |
|---|---|---|
| Short Interest | — | 0.07% |
NMRD and NVDA split the risk & sentiment factors evenly.
Dig deeper: NMRD overview, NMRD financials, NVDA overview, NVDA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.